Skip to content

A cohort study for the effect of different antihypertensive drugs on bone mineral density

A cohort study for the effect of different antihypertensive drugs on bone mineral density

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022512
Enrollment
Unknown
Registered
2019-04-14
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension, Osteoporosis

Interventions

Case series:different antihypertensive drugs

Sponsors

Shunde Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. = 40 year old female, = 50 year old male; 2. Have a history of hypertension; 3. Patients take the usual doses; 4. Postmenopausal female patients.

Exclusion criteria

Exclusion criteria: 1. Take the medicine for less than 6 months; 2. Irregular medication; 3. Combined use of calcium channel blockers and non-calcium channel blockers; 4. Have done anti-osteoporosis treatment; 5. Long-term use of various drugs that affect bone density, such as: hormones, anti-depression, etc.; 6. combined with hyperthyroidism, hyperparathyroidism, adrenaline and other diseases that may affect the purpose of the study; 7. Taking non-dihydropyridines.

Design outcomes

Primary

MeasureTime frame
bone mineral density;Glu;ca2;ALP;Bone turnover biochemical index;

Countries

China

Contacts

Public ContactWang Zhi-Yun

Department of Spine Surgery, Shunde Hospital, Southern Medical University (The First People’s Hospital of Shunde Foshan)

dragon201@126.com+86 18620866697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026